FR08C0046I2 - Reconstitution in vitro de virus a arn de polarite negative segmentes - Google Patents
Reconstitution in vitro de virus a arn de polarite negative segmentesInfo
- Publication number
- FR08C0046I2 FR08C0046I2 FR08C0046C FR08C0046C FR08C0046I2 FR 08C0046 I2 FR08C0046 I2 FR 08C0046I2 FR 08C0046 C FR08C0046 C FR 08C0046C FR 08C0046 C FR08C0046 C FR 08C0046C FR 08C0046 I2 FR08C0046 I2 FR 08C0046I2
- Authority
- FR
- France
- Prior art keywords
- segmented
- polarity
- rna viruses
- negative rna
- vitro reconstruction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14364599P | 1999-07-14 | 1999-07-14 | |
GBGB9916794.2A GB9916794D0 (en) | 1999-07-16 | 1999-07-16 | In vitro virus reconstitution |
PCT/GB2000/002710 WO2001004333A1 (en) | 1999-07-14 | 2000-07-14 | In vitro reconstitution of segmented negative-strand rna viruses |
Publications (2)
Publication Number | Publication Date |
---|---|
FR08C0046I1 FR08C0046I1 (fr) | 2009-01-02 |
FR08C0046I2 true FR08C0046I2 (fr) | 2011-11-25 |
Family
ID=26315773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR08C0046C Active FR08C0046I2 (fr) | 1999-07-14 | 2008-11-13 | Reconstitution in vitro de virus a arn de polarite negative segmentes |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1194580B2 (nl) |
AT (1) | ATE353370T1 (nl) |
AU (1) | AU5998400A (nl) |
CA (1) | CA2379012C (nl) |
CY (2) | CY1106404T1 (nl) |
DE (5) | DE122008000056I1 (nl) |
DK (1) | DK1194580T4 (nl) |
ES (1) | ES2278621T5 (nl) |
FR (1) | FR08C0046I2 (nl) |
LU (1) | LU91367I2 (nl) |
NL (4) | NL300301I2 (nl) |
WO (1) | WO2001004333A1 (nl) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060080249A (ko) | 1998-06-12 | 2006-07-07 | 마운트 시나이 스쿨 오브 메디신 오브 뉴욕 유니버시티 | 변형된 인터페론 길항물질을 보유하고, 백신 및 약제로사용되는 약독화된 네거티브 가닥 바이러스 |
AU2002309133A1 (en) * | 2001-04-17 | 2002-10-28 | Institut Pasteur | Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same |
KR101113432B1 (ko) | 2002-02-13 | 2012-02-29 | 위스콘신 얼럼나이 리서어치 화운데이션 | 인플루엔자 바이러스 벡터의 패키징을 위한 신호 |
FR2866031B1 (fr) * | 2004-02-11 | 2012-10-19 | David Francois Joseph Millet | Chimere de virus pathogene emergent, medicament la contenant et utilisation en therapie antivirale |
JP5600375B2 (ja) | 2004-03-09 | 2014-10-01 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | インフルエンザウイルスワクチン |
CA2610632C (en) | 2004-06-01 | 2022-10-04 | Mount Sinai School Of Medicine Of New York University | Genetically engineered swine influenza virus and uses thereof |
PT1831357E (pt) | 2004-12-24 | 2012-12-17 | Univ Erasmus Medical Ct | Obtenção de vírus da gripe |
US8137676B2 (en) | 2005-02-15 | 2012-03-20 | Mount Sinai School Of Medicine | Genetically engineered equine influenza virus and uses thereof |
US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7790434B2 (en) | 2005-06-21 | 2010-09-07 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral RNA in canine cells |
AU2006262380A1 (en) | 2005-06-21 | 2007-01-04 | Medimmune, Llc | Methods and compositions for expressing a heterologous protease |
US11707520B2 (en) | 2005-11-03 | 2023-07-25 | Seqirus UK Limited | Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
JP2009514850A (ja) | 2005-11-04 | 2009-04-09 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | アジュバントとして減少した量の水中油型エマルションを有するインフルエンザワクチン |
AU2006310337B9 (en) | 2005-11-04 | 2013-11-28 | Novartis Ag | Adjuvanted influenza vaccines including cytokine-inducing agents |
EP1951299B1 (en) | 2005-11-04 | 2012-01-04 | Novartis Vaccines and Diagnostics S.r.l. | Influenza vaccines including combinations of particulate adjuvants and immunopotentiators |
BRPI0618254A2 (pt) | 2005-11-04 | 2011-08-23 | Novartis Vaccines & Diagnostic | emulsões com agente tensoativo de fase aquosa livre para fornecer adjuvante às vacinas contra influenza dividido |
JP2009514838A (ja) | 2005-11-04 | 2009-04-09 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | 細胞培養物において増殖されたインフルエンザウイルスから調製された非ビリオン抗原を含むアジュバントワクチン |
PT2529747T (pt) | 2005-12-02 | 2018-05-09 | Icahn School Med Mount Sinai | Vírus da doença de newcastle quiméricos que apresentam proteínas de superfície não nativas e suas utilizações |
EP1976559B3 (en) | 2006-01-27 | 2020-02-19 | Seqirus UK Limited | Influenza vaccines containing hemagglutinin and matrix proteins |
EP2004226A1 (en) | 2006-03-24 | 2008-12-24 | Novartis Vaccines and Diagnostics GmbH & Co. KG | Storage of influenza vaccines without refrigeration |
WO2007124327A2 (en) * | 2006-04-19 | 2007-11-01 | Medimmune Llc. | Methods and compositions for expressing negative-sense viral rna in canine cells |
GB0614460D0 (en) | 2006-07-20 | 2006-08-30 | Novartis Ag | Vaccines |
BRPI0716536A2 (pt) | 2006-09-11 | 2013-09-24 | Novartis Ag | produÇço de vacinas de vÍrus influenza, sem a utilizaÇço de ovos |
CA2671629C (en) | 2006-12-06 | 2017-08-15 | Novartis Ag | Vaccines including antigen from four strains of influenza virus |
WO2008147496A2 (en) | 2007-05-04 | 2008-12-04 | Warf - Wisconsin Alumni Research Foundation | Neuraminidase-deficient live influenza vaccines |
US8043856B2 (en) | 2007-06-14 | 2011-10-25 | Wisconsin Alumni Research Foundation | Adenoviral vectors for influenza virus production |
WO2009001217A2 (en) | 2007-06-27 | 2008-12-31 | Novartis Ag | Low-additive influenza vaccines |
EP2045323A1 (en) * | 2007-10-05 | 2009-04-08 | Avir Green Hills Biotechnology Research Development Trade Ag | Linear expression constructs for production of influenza virus particles |
GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
ES2535101T3 (es) | 2008-03-18 | 2015-05-05 | Novartis Ag | Mejoras en la preparación de antígenos en vacuna de virus de la gripe |
EP2233568A1 (en) | 2009-03-19 | 2010-09-29 | Avir Green Hills Biotechnology Research Development Trade AG | Novel method for generation of RNA virus |
ES2550179T3 (es) | 2009-02-05 | 2015-11-05 | Icahn School Of Medicine At Mount Sinai | Virus quiméricos de la enfermedad de Newcastle y usos de los mismos |
ES2552383T3 (es) | 2009-02-10 | 2015-11-27 | Novartis Ag | Regímenes de vacuna de la gripe para cepas asociadas a pandemias |
ES2608841T3 (es) | 2009-02-10 | 2017-04-17 | Seqirus UK Limited | Vacunas contra la gripe con cantidades reducidas de escualeno |
US20120093860A1 (en) | 2009-02-10 | 2012-04-19 | Novartis Ag | Influenza vaccines with increased amounts of h3 antigen |
WO2010117786A1 (en) | 2009-03-30 | 2010-10-14 | Mount Sinai School Of Medicine Of New York University | Influenza virus vaccines and uses thereof |
CN102548577A (zh) | 2009-04-27 | 2012-07-04 | 诺华有限公司 | 用于抵抗流感的佐剂疫苗 |
WO2011014504A1 (en) | 2009-07-27 | 2011-02-03 | Mount Sinai School Of Medicine Of New York University | Recombinant influenza virus vectors and uses thereof |
US8828406B2 (en) | 2009-07-30 | 2014-09-09 | Icahn School Of Medicine At Mount Sinai | Influenza viruses and uses thereof |
JP2013504556A (ja) | 2009-09-10 | 2013-02-07 | ノバルティス アーゲー | 気道疾患に対する組み合わせワクチン |
EP3248615A1 (en) | 2010-03-30 | 2017-11-29 | Mount Sinai School of Medicine of New York University | Influenza virus vaccines and uses thereof |
KR20130115105A (ko) | 2010-06-02 | 2013-10-21 | 박스터 헬쓰케어 에스에이 | Rna 바이러스를 생산하는 방법 및 헬퍼 바이러스 |
US9101653B2 (en) | 2011-08-26 | 2015-08-11 | Wisconsin Alumni Research Foundation | Influenza viruses with mutant PB2 gene segment as live attenuated vaccines |
EP2758075B1 (en) | 2011-09-20 | 2023-05-03 | Icahn School of Medicine at Mount Sinai | Influenza virus vaccines and uses thereof |
EP2768528A1 (en) | 2011-10-20 | 2014-08-27 | Novartis AG | Adjuvanted influenza b virus vaccines for pediatric priming |
EP2708552A1 (en) | 2012-09-12 | 2014-03-19 | Medizinische Universität Wien | Influenza virus |
GB201218195D0 (en) | 2012-10-10 | 2012-11-21 | Istituto Zooprofilattico Sperimentale Delle Venezie | Composition |
BR112015014482A2 (pt) | 2012-12-18 | 2017-11-21 | Icahn School Med Mount Sinai | vacinas para vírus influenza e seus usos |
US20140274806A1 (en) | 2013-03-15 | 2014-09-18 | Synthetic Genomics Vaccines | Influenza virus reassortment |
WO2014115104A1 (en) * | 2013-01-23 | 2014-07-31 | Novartis Ag | Influenza virus reassortment |
WO2014159960A1 (en) | 2013-03-14 | 2014-10-02 | Icahn School Of Medicine At Mount Sinai | Antibodies against influenza virus hemagglutinin and uses thereof |
CA2905272A1 (en) | 2013-03-14 | 2014-10-02 | Icahn School Of Medicine At Mount Sinai | Newcastle disease viruses and uses thereof |
JP6857498B2 (ja) | 2014-02-27 | 2021-04-14 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | 癌を処置するための併用方法 |
US10053671B2 (en) | 2014-06-20 | 2018-08-21 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
CL2014003146A1 (es) * | 2014-11-20 | 2015-06-12 | Univ Santiago Chile | Método para producir virus arn monocatenario negativo; plásmido recombinante funcional en células animales, que consta de un esqueleto pss-urg; método de obtención de partículas virales; y uso para expresar arn, proteínas autógenas o exógenas al virus. |
WO2016118937A1 (en) | 2015-01-23 | 2016-07-28 | Icahn School Of Medicine At Mount Sinai | Influenza virus vaccination regimens |
MX2017010908A (es) | 2015-02-26 | 2017-12-07 | Boehringer Ingelheim Vetmedica Gmbh | Vacuna bivalente contra el virus de gripe porcina. |
WO2016207853A2 (en) | 2015-06-26 | 2016-12-29 | Seqirus UK Limited | Antigenically matched influenza vaccines |
JP6830070B2 (ja) | 2015-07-07 | 2021-02-17 | セキラス ユーケー リミテッドSeqirus UK Limited | インフルエンザ効力アッセイ |
JP2018530314A (ja) | 2015-08-28 | 2018-10-18 | ウィスコンシン アルムニ リサーチ ファンデイション | ウイルス様粒子からの感染性インフルエンザウイルスの生成 |
JP7237344B2 (ja) | 2016-06-15 | 2023-03-13 | アイカーン スクール オブ メディシン アット マウント サイナイ | インフルエンザウイルス血球凝集素タンパク質及びその使用 |
EP3606555A4 (en) | 2017-04-07 | 2021-08-04 | Icahn School of Medicine at Mount Sinai | INFLUENZA VIRUS TYPE B ANTI-NEURAMINIDASE ANTIBODIES AND THEIR USES |
JOP20190256A1 (ar) | 2017-05-12 | 2019-10-28 | Icahn School Med Mount Sinai | فيروسات داء نيوكاسل واستخداماتها |
US11851648B2 (en) | 2019-02-08 | 2023-12-26 | Wisconsin Alumni Research Foundation (Warf) | Humanized cell line |
JP2022551805A (ja) | 2019-08-27 | 2022-12-14 | ウィスコンシン アルムニ リサーチ ファンデイション | 卵内複製のための安定化されたhaを持つ組換えインフルエンザウイルス |
CN111363727B (zh) * | 2020-01-20 | 2021-09-24 | 武汉大学 | 携带幽门螺杆菌的重组流感病毒、宿主细胞及其制备方法与应用 |
EP3896077A1 (en) | 2020-04-16 | 2021-10-20 | Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH | Influenza virus-like particles (vlps) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840520A (en) * | 1989-08-28 | 1998-11-24 | Aviron | Recombinant negative strand RNA virus expression systems |
ES2373405T3 (es) * | 1999-04-06 | 2012-02-03 | Wisconsin Alumni Research Foundation | Virus de la gripe recombinantes para vacunas y terapia génica. |
-
2000
- 2000-07-14 DE DE122008000056C patent/DE122008000056I1/de active Pending
- 2000-07-14 DK DK00946097.3T patent/DK1194580T4/da active
- 2000-07-14 DE DE200712000061 patent/DE122007000061I2/de active Active
- 2000-07-14 EP EP00946097A patent/EP1194580B2/en not_active Expired - Lifetime
- 2000-07-14 AT AT00946097T patent/ATE353370T1/de active
- 2000-07-14 ES ES00946097T patent/ES2278621T5/es not_active Expired - Lifetime
- 2000-07-14 CA CA2379012A patent/CA2379012C/en not_active Expired - Lifetime
- 2000-07-14 DE DE60033284.5T patent/DE60033284T3/de not_active Expired - Lifetime
- 2000-07-14 AU AU59984/00A patent/AU5998400A/en not_active Abandoned
- 2000-07-14 WO PCT/GB2000/002710 patent/WO2001004333A1/en active IP Right Grant
- 2000-07-14 DE DE122008000057C patent/DE122008000057I1/de active Pending
- 2000-07-14 DE DE200712000070 patent/DE122007000070I1/de active Pending
-
2007
- 2007-03-20 CY CY20071100397T patent/CY1106404T1/el unknown
- 2007-09-21 CY CY200700023C patent/CY2007023I1/el unknown
- 2007-09-21 LU LU91367C patent/LU91367I2/fr unknown
- 2007-09-21 NL NL300301C patent/NL300301I2/nl unknown
- 2007-09-21 NL NL300294C patent/NL300294I2/nl unknown
-
2008
- 2008-11-13 FR FR08C0046C patent/FR08C0046I2/fr active Active
- 2008-11-13 NL NL300369C patent/NL300369I1/nl unknown
- 2008-11-13 NL NL300368C patent/NL300368I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
DE60033284T2 (de) | 2007-10-25 |
CY2007023I2 (el) | 2009-11-04 |
DK1194580T3 (da) | 2007-04-10 |
NL300368I1 (nl) | 2009-01-05 |
DE122008000056I1 (de) | 2009-04-09 |
DE122007000061I1 (de) | 2007-12-20 |
DE122008000057I1 (de) | 2009-04-09 |
NL300301I1 (nl) | 2008-01-02 |
EP1194580B1 (en) | 2007-02-07 |
NL300301I2 (nl) | 2008-10-01 |
WO2001004333A1 (en) | 2001-01-18 |
CY1106404T1 (el) | 2010-07-28 |
DE60033284T3 (de) | 2014-10-30 |
NL300368I2 (nl) | 2017-08-03 |
EP1194580B2 (en) | 2010-08-25 |
ES2278621T5 (es) | 2011-02-02 |
EP1194580A1 (en) | 2002-04-10 |
ES2278621T3 (es) | 2007-08-16 |
DE122007000070I1 (de) | 2008-01-31 |
CA2379012A1 (en) | 2001-01-18 |
NL300294I1 (nl) | 2007-12-03 |
CA2379012C (en) | 2013-07-02 |
DE60033284D1 (de) | 2007-03-22 |
CY2007023I1 (el) | 2009-11-04 |
DE122007000061I2 (de) | 2011-07-21 |
ATE353370T1 (de) | 2007-02-15 |
LU91367I2 (fr) | 2007-11-21 |
AU5998400A (en) | 2001-01-30 |
NL300294I2 (nl) | 2008-10-01 |
FR08C0046I1 (fr) | 2009-01-02 |
DK1194580T4 (da) | 2011-01-03 |
NL300369I1 (nl) | 2009-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR08C0046I2 (fr) | Reconstitution in vitro de virus a arn de polarite negative segmentes | |
CY1110964T1 (el) | Μεθοδος παραγωγης εμβολιων μεγαλης κλιμακας | |
CA2401117A1 (en) | Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell | |
CA2205015A1 (en) | Method for producing biologicals in protein-free culture | |
DK1108787T3 (da) | Fremstilling af vacciner | |
FR07C0012I2 (fr) | Methode de desassemblage-reassemblage in vitro de particules viroides (vlp) du papillomavirus | |
DE69626022D1 (de) | Verfahren zur industriellen herstellung eines japanischen enkephalitis impfstoffes, und so erhaltener impfstoff | |
TH58373B (th) | อิมมูโนเจนที่ถูกเพิ่มกำลัง สำหรับวัคซีนที่ไม่ถูกกระตุ้นเพื่อต่อสู้กับโรคที่เป็นการติดเชื้อที่มีสาเหตุมาจากกลุ่มของเจเปเนส เอนซีฟาลิทีสไวรัส และวิธีการเพื่อผลิตสิ่งนั้น |